脑梗死肝阳化风证患者外周血单个核细胞蛋白质组学研究
|
摘要
研究目的:
1.建立脑梗死肝阳化风证、阴虚风动证高分辨率的二维凝胶电泳图谱;
2.应用比较蛋白质组学方法分析并鉴定脑梗死肝阳化风证和阴虚风动证的相关蛋白质:
3.从腺苷酰环化酶(adenylate cyclase,AC)在脑梗死肝阳化风证及阴虚风动证中的基因表达,探讨中医肝阳化风证与阴虚风动证的关联性与差异性。
研究方法:设脑梗死肝阳化风证组、健康人对照组、脑梗死阴虚风动证对照组3组,严格按照疾病诊断、证侯诊断标准,选择脑梗死肝阳化风证患者15例,脑梗死阴虚风动证患者15例,按照纳入排除标准,选择健康人15例,取外周静脉血分离单个核细胞提取蛋白质,经双向凝胶电泳,考马斯亮蓝染色获取凝胶图谱,PDQuestV7.3.1软件比较分析3组图谱并识别脑梗死肝阳化风证与阴虚风动证的差异表达蛋白质点及相同表达蛋白质点。MALDI-TOF-MS质谱仪进行肽质量指纹谱的鉴定,Mascot检索软件检索软件在Swiss-prot数据库搜索进行蛋白鉴定,检索出相关蛋白质的名称、分类及功能。并用RT-PCR技术检测腺苷酰环化酶(adenylate cyclase,AC)在脑梗死肝阳化风证及阴虚风动证中的基因表达情况。
研究结果:
1.初步建立了脑梗死肝阳化风证、健康人组、脑梗死阴虚风动证患者外周血单个核细胞2-DE图谱,分别获得蛋白质点459个,552个,644个;
2.PDQuest V7.3.1软件比较分析,发现了脑梗死肝阳化风证与阴虚风动证的相同蛋白质点8个,差异蛋白质点23个;
3.MALDI-TOF-MS质谱分析和MASCOT软件检索Swissprot蛋白质数据库鉴定出27个蛋白质斑点,共20种蛋白质,各种蛋白质点在3组的表达各异,经肝阳化风组与健康对照组,阴虚风动组与健康对照组,以及肝阳化风组与阴虚风动组的相互比较,发现肝阳化风组与阴虚风动组差异蛋白质点23个,鉴定出22个共15种蛋白质,分别为成帽蛋白、血小板凝血酶敏感蛋白-1、腺苷酰环化酶联合蛋白-1、鸟苷二磷酸解离抑制因子2、γ-肌动蛋白、钙结合蛋白、肌球蛋白调节轻链、抗增殖蛋白、谷胱甘肽转移酶ω-1、硫氧还蛋白过氧(化)物酶-1、Visual cortex cDNA、假想蛋白、Ras抑制蛋白、受体相关蛋白/RNA聚合酶相关蛋白、锌结合蛋白;相同表达蛋白质点8个,鉴定出6个蛋白质点共5种蛋白质.分别为核内不均一核糖核蛋白、丝氨酸/苏氨酸特异蛋白激酶、踝蛋白、纤维蛋白素原β-链前体、纤维蛋白素原α链前体,包括细胞骨架蛋白,信号传导蛋白,氧化还原蛋白,凋亡相关蛋白,血液蛋白等多类蛋白质表达异常;
4.腺苷酰环化酶(adenylate cyclase,AC)mRNA在脑梗死肝阳化风组中表达缺失,阴虚风动组中表达明显下调,且表达量有显著差异性(P＜0.05)。
研究结论:
1.初步建立了脑梗死肝阳化风证、脑梗死阴虚风动证及健康人PBMC2-DE图谱,并通过MODI-TOP-MS技术鉴定分析出脑梗死肝阳化风证与阴虚风动证相同表达蛋白与差异表达蛋白,提示本病相类证有共同的物质基础,同病异证有不同的本质内涵。
2.RT-PCR验证ACmRNA在脑梗死肝阳化风证与阴虚风动证中的表达与蛋白组学检测结果一致,证明了蛋白组学技术的稳定性和结果的准确性。
Objective:
1. TO establish cerebral infarction Ganyang-Huafeng Syndrome (GYHF) and Yinxu-Fengdong Syndrome(YXFD) high-resolution map of the two-dimensional gel electrophoresis;
2. Using Comparison of proteomics methods to analyze and identify different proteins in cerebral infarction Ganyang-Huafeng Syndrome(GYHF) and Yinxu- Fengdong Syndrome(YXFD);
3. From the gene expression of adenylate cyclase (AC) in cerebral infarction Ganyang-Huafeng Syndrome(GYHF) and Yinxu-Fengdong Syndrome(YXFD), to explore the relevance and the difference of Chinese medicine Ganyang-Huafeng Syndrome(GYHF) and Yinxu-Fengdong Syndrome(YXFD).
Methods: Design 3 groups, cerebral infarction Ganyang-Huafeng Syndrome group(GYHF), Yinxu-Fengdong Syndrome group (YXFD),and healthy control group,in strict accordance with the disease diagnosis, diagnostic criteria syndrome, cerebral infarction choice of Ganyang-Huafeng Syndrome(GYHF)patients of 15 cases, Yinxu-Fengdong Syndrome (YXFD) patients of 15 cases, in accordance with the exclusion criteria included, choose healthy people in 15 cases, isolated from peripheral blood mononuclear cells extracted proteins. The two-dimensional gel electrophoresis, Coomassie brilliant blue staining patterns of access to gel, PDQuest V7.3.1 software comparative analysis of the three groups and identify differentially expressed proteins and the same expression of proteins of Ganyang-Huafeng Syndrome(GYHF)and Yinxu-Fengdong Syndrome(YXFD). MALDI-TOF-MS mass spectrometer for peptide mass fingerprint identification, Mascot retrieval software in the Swiss-prot database search for protein identification, retrieval related protein's name, classification and functions. By RT-PCR technology to detect gene expression of adenylate cyclase(AC) in the cerebral infarction Ganyang-Huafeng Syndrome(GYHF)and Yinxu-Fengdong Syndrome(YXFD).
Results:
1. Initially established PBMC 2-DE maps of Ganyang-Huafeng Syndrome(GYHF) patients and Yinxu-Fengdong Syndrome(YXFD) patients and healthy group, respectively proteins are 459, 552,644;
2. PDQuest V7.3.1 software comparative analysis ,and found 8 same proteins and 23 different proteins in Ganyang-Huafeng Syndrome (GYHF) group and Yinxu-Fengdong Syndrome(YXFD)group.
3. MALDI-TOF-MS mass Spectrometry analysis and MASCOT software retrieval Swissprot protein database identified 27 protein spots, a total of 20 kinds of proteins, various protein spots express different in different groups,compared with Ganyang-Huafeng Syndrome(GYHF) group and healthy group, Yinxu-Fengdong Syndrome(YXFD)group and healthy group, Ganyang-Huafeng Syndrome(GYHF) group and Yinxu-Fengdong Syndrome(YXFD)group,we found 23 different protein spots, 22 identified with 15 kinds of proteins, they are Capping protein, Thrombospondin-1, Adenylyl cyclase-associated protein 1, Rho GDP-dissociation inhibitor 2,γ-actin, Transgelin-2, Prohibitin, myosin regulatory light chain,Glutathione transferase omega-1, Thioredoxin-dependent peroxide reductase, Visual cortex cDNA, Hypothetical protein NEDD5, Ras suppressor protein,RAP1B protein, ZYX protein [Fragment]. 8 same protein spots, 6 identified with 5 kinds of proteins,they are Heterogeneous nuclear ribonucleo proteinK, serine/threonine-specific protein kinase, Talin-1, fibrinogen beta chain precursor, fibrinogen alpha chain precursor. Including the cytoskeleton protein, signal transduction protein, redox protein, apoptosis-related protein, blood protein, and other types of abnormal proteins.
4. Expression of ACmRNA in Ganyang-Huafeng Syndrome(GYHF) group was missing, Yinxu-Fengdong Syndrome(YXFD)group was significantly down-regulated, and the expression have significant difference (P <0.05).
Conclusion:
1.Initially established cerebral infarction Ganyang-Huafeng Syndrome(GYHF) , Yinxu-Fengdong Syndrome(YXFD) and healthy PBMC 2-DE maps, Through MODI-TOP-MS analysis of Ganyang-Huafeng Syndrome(GYHF) , Yinxu-Fengdong Syndrome (YXFD) , the same protein expression and protein expression of differences, suggesting that the disease similar cards have a common material basis of different ,and have different connotations of the essence.
2. RT-PCR verified ACmRNA expression in Ganyang-Huafeng Syndrome(GYHF) and Yinxu-Fengdong Syndrome(YXFD) ,the results is the same with protein test results, Proved the stability of Proteomics technology and the accuracy of the results.
1.建立脑梗死肝阳化风证、阴虚风动证高分辨率的二维凝胶电泳图谱;
2.应用比较蛋白质组学方法分析并鉴定脑梗死肝阳化风证和阴虚风动证的相关蛋白质:
3.从腺苷酰环化酶(adenylate cyclase,AC)在脑梗死肝阳化风证及阴虚风动证中的基因表达,探讨中医肝阳化风证与阴虚风动证的关联性与差异性。
研究方法:设脑梗死肝阳化风证组、健康人对照组、脑梗死阴虚风动证对照组3组,严格按照疾病诊断、证侯诊断标准,选择脑梗死肝阳化风证患者15例,脑梗死阴虚风动证患者15例,按照纳入排除标准,选择健康人15例,取外周静脉血分离单个核细胞提取蛋白质,经双向凝胶电泳,考马斯亮蓝染色获取凝胶图谱,PDQuestV7.3.1软件比较分析3组图谱并识别脑梗死肝阳化风证与阴虚风动证的差异表达蛋白质点及相同表达蛋白质点。MALDI-TOF-MS质谱仪进行肽质量指纹谱的鉴定,Mascot检索软件检索软件在Swiss-prot数据库搜索进行蛋白鉴定,检索出相关蛋白质的名称、分类及功能。并用RT-PCR技术检测腺苷酰环化酶(adenylate cyclase,AC)在脑梗死肝阳化风证及阴虚风动证中的基因表达情况。
研究结果:
1.初步建立了脑梗死肝阳化风证、健康人组、脑梗死阴虚风动证患者外周血单个核细胞2-DE图谱,分别获得蛋白质点459个,552个,644个;
2.PDQuest V7.3.1软件比较分析,发现了脑梗死肝阳化风证与阴虚风动证的相同蛋白质点8个,差异蛋白质点23个;
3.MALDI-TOF-MS质谱分析和MASCOT软件检索Swissprot蛋白质数据库鉴定出27个蛋白质斑点,共20种蛋白质,各种蛋白质点在3组的表达各异,经肝阳化风组与健康对照组,阴虚风动组与健康对照组,以及肝阳化风组与阴虚风动组的相互比较,发现肝阳化风组与阴虚风动组差异蛋白质点23个,鉴定出22个共15种蛋白质,分别为成帽蛋白、血小板凝血酶敏感蛋白-1、腺苷酰环化酶联合蛋白-1、鸟苷二磷酸解离抑制因子2、γ-肌动蛋白、钙结合蛋白、肌球蛋白调节轻链、抗增殖蛋白、谷胱甘肽转移酶ω-1、硫氧还蛋白过氧(化)物酶-1、Visual cortex cDNA、假想蛋白、Ras抑制蛋白、受体相关蛋白/RNA聚合酶相关蛋白、锌结合蛋白;相同表达蛋白质点8个,鉴定出6个蛋白质点共5种蛋白质.分别为核内不均一核糖核蛋白、丝氨酸/苏氨酸特异蛋白激酶、踝蛋白、纤维蛋白素原β-链前体、纤维蛋白素原α链前体,包括细胞骨架蛋白,信号传导蛋白,氧化还原蛋白,凋亡相关蛋白,血液蛋白等多类蛋白质表达异常;
4.腺苷酰环化酶(adenylate cyclase,AC)mRNA在脑梗死肝阳化风组中表达缺失,阴虚风动组中表达明显下调,且表达量有显著差异性(P＜0.05)。
研究结论:
1.初步建立了脑梗死肝阳化风证、脑梗死阴虚风动证及健康人PBMC2-DE图谱,并通过MODI-TOP-MS技术鉴定分析出脑梗死肝阳化风证与阴虚风动证相同表达蛋白与差异表达蛋白,提示本病相类证有共同的物质基础,同病异证有不同的本质内涵。
2.RT-PCR验证ACmRNA在脑梗死肝阳化风证与阴虚风动证中的表达与蛋白组学检测结果一致,证明了蛋白组学技术的稳定性和结果的准确性。
Objective:
1. TO establish cerebral infarction Ganyang-Huafeng Syndrome (GYHF) and Yinxu-Fengdong Syndrome(YXFD) high-resolution map of the two-dimensional gel electrophoresis;
2. Using Comparison of proteomics methods to analyze and identify different proteins in cerebral infarction Ganyang-Huafeng Syndrome(GYHF) and Yinxu- Fengdong Syndrome(YXFD);
3. From the gene expression of adenylate cyclase (AC) in cerebral infarction Ganyang-Huafeng Syndrome(GYHF) and Yinxu-Fengdong Syndrome(YXFD), to explore the relevance and the difference of Chinese medicine Ganyang-Huafeng Syndrome(GYHF) and Yinxu-Fengdong Syndrome(YXFD).
Methods: Design 3 groups, cerebral infarction Ganyang-Huafeng Syndrome group(GYHF), Yinxu-Fengdong Syndrome group (YXFD),and healthy control group,in strict accordance with the disease diagnosis, diagnostic criteria syndrome, cerebral infarction choice of Ganyang-Huafeng Syndrome(GYHF)patients of 15 cases, Yinxu-Fengdong Syndrome (YXFD) patients of 15 cases, in accordance with the exclusion criteria included, choose healthy people in 15 cases, isolated from peripheral blood mononuclear cells extracted proteins. The two-dimensional gel electrophoresis, Coomassie brilliant blue staining patterns of access to gel, PDQuest V7.3.1 software comparative analysis of the three groups and identify differentially expressed proteins and the same expression of proteins of Ganyang-Huafeng Syndrome(GYHF)and Yinxu-Fengdong Syndrome(YXFD). MALDI-TOF-MS mass spectrometer for peptide mass fingerprint identification, Mascot retrieval software in the Swiss-prot database search for protein identification, retrieval related protein's name, classification and functions. By RT-PCR technology to detect gene expression of adenylate cyclase(AC) in the cerebral infarction Ganyang-Huafeng Syndrome(GYHF)and Yinxu-Fengdong Syndrome(YXFD).
Results:
1. Initially established PBMC 2-DE maps of Ganyang-Huafeng Syndrome(GYHF) patients and Yinxu-Fengdong Syndrome(YXFD) patients and healthy group, respectively proteins are 459, 552,644;
2. PDQuest V7.3.1 software comparative analysis ,and found 8 same proteins and 23 different proteins in Ganyang-Huafeng Syndrome (GYHF) group and Yinxu-Fengdong Syndrome(YXFD)group.
3. MALDI-TOF-MS mass Spectrometry analysis and MASCOT software retrieval Swissprot protein database identified 27 protein spots, a total of 20 kinds of proteins, various protein spots express different in different groups,compared with Ganyang-Huafeng Syndrome(GYHF) group and healthy group, Yinxu-Fengdong Syndrome(YXFD)group and healthy group, Ganyang-Huafeng Syndrome(GYHF) group and Yinxu-Fengdong Syndrome(YXFD)group,we found 23 different protein spots, 22 identified with 15 kinds of proteins, they are Capping protein, Thrombospondin-1, Adenylyl cyclase-associated protein 1, Rho GDP-dissociation inhibitor 2,γ-actin, Transgelin-2, Prohibitin, myosin regulatory light chain,Glutathione transferase omega-1, Thioredoxin-dependent peroxide reductase, Visual cortex cDNA, Hypothetical protein NEDD5, Ras suppressor protein,RAP1B protein, ZYX protein [Fragment]. 8 same protein spots, 6 identified with 5 kinds of proteins,they are Heterogeneous nuclear ribonucleo proteinK, serine/threonine-specific protein kinase, Talin-1, fibrinogen beta chain precursor, fibrinogen alpha chain precursor. Including the cytoskeleton protein, signal transduction protein, redox protein, apoptosis-related protein, blood protein, and other types of abnormal proteins.
4. Expression of ACmRNA in Ganyang-Huafeng Syndrome(GYHF) group was missing, Yinxu-Fengdong Syndrome(YXFD)group was significantly down-regulated, and the expression have significant difference (P <0.05).
Conclusion:
1.Initially established cerebral infarction Ganyang-Huafeng Syndrome(GYHF) , Yinxu-Fengdong Syndrome(YXFD) and healthy PBMC 2-DE maps, Through MODI-TOP-MS analysis of Ganyang-Huafeng Syndrome(GYHF) , Yinxu-Fengdong Syndrome (YXFD) , the same protein expression and protein expression of differences, suggesting that the disease similar cards have a common material basis of different ,and have different connotations of the essence.
2. RT-PCR verified ACmRNA expression in Ganyang-Huafeng Syndrome(GYHF) and Yinxu-Fengdong Syndrome(YXFD) ,the results is the same with protein test results, Proved the stability of Proteomics technology and the accuracy of the results.
引文
[1]余宗阳.杜建.蛋白质组学与中医证实质研究.中国中西医结合杂志,2004,24(9):844-846.
[2]金益强,黎杏群,胡随瑜,等。.肝风内动证三亚型的病理生理学基础研究.中国中西结合杂志,1993,13(7):391-397.
[3]王顺道,杜梦华,解庆凡,等.中风病急性期证候演变规律的研究[J].中国中医急症,1996,5(3):121-124.
[4]金益强冲医肝脏象现代研究与临床.人民卫生出版社,北京.2000,2(1):226-227,238,240-241.
[5]潘其民,陈国林,赵玉秋,等.中医肝病流行病学调查.中西医结合杂志 1991;11(3):153-155.
[6]申维玺.论中医证本质的科学内涵.中国中医基础医学杂志 2001;7(6):410-414.
[7]Wright AF.Neurogenetics Ⅱ:complex disorders.J Neurol Neurosurg Psychiatry.2005 May;76(5):623-31.
[8]中华神经科学会.各类脑血管疾病诊断要点[J].中华内科杂志,1996;29(6):379.
[9]郑莜萸主编.中药新药治疗中风的临床指导原则.北京:中国医药科技出版社,2002.
[10]陈肃标,谢素和,曾庆馀.提高外周血淋巴细胞梯度离心分离率,汕头大学医学院学报;2001,14(2):135-137.
[11]Bradford MM.A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Anal Biochem 1976;72:248-54.
[12]Kurt K,Michael F,Gert L.A rat brain protein expression map including cytosolic and enriched mitochondfial and microsomal fractions.Electrophoresis,2003,24,1847-1870.
[13]李家邦,李瑛,熊国良,等.肝阳化风证病理生理学基础的进一步研究湖南医科大学学报 2000,25(4):343-346.
[14]Gendron A,Teitelbaum J,Cossene C,et al Tempo ral effects of left versus right middle cerebral artery occlusion on spleen lymphoc yte subsets and mitogeic response inWistar rats[J]Brain Res,2002,955(1-2)85-97.
[15]Campsnells M,Sciorati C,Tarozzo G,et al.Flow cytometric analysis of inflammatory cells in ischemic rat brain[J]Stroke,2002,33(2):586-592.
[16]Gulesserian T,Kim S H,Fountoulakis M,et al.Aberrant expression of centractin and capping proteins,integral constituents of the dynactin complex,in fetal down syndrome brain[J].Biochem Biophys Res Commun,2002,291(1):62-67.
[17]Burridge K,Chrzanowska-Wodnicka M.Focal adhesions,contractility,and signaling[J].Annu Rev Cell Dev Biol,1996,12:463-518.
[18]Borowsky ML,Hynes RO.Layilin,a novel talin- binding transmembrane protein homologous with C-type lectins,is localized in membrane ruffles[J].J Cell Biol,1998,143(2):429-442.
[19]Izard T,Evans G,Borgon RA,et al.Vinculin activation by talin through helical bundle conversion[J].Nature,2004,427(6970):171-175.
[20]Bois PR,O′Hara BP,Nietlispach D,et al.The vinculin binding sites of talin and alpha- actinin are sufficient to activate vinculin[J].J Biol Chem,2006,281(11):7228-7236.
[21]Mili S,Shu HJ,Zhao Y,et al.Distinct RNP complexes of shuttling hnRNP proteins with pre2mRNA and mRNA:candidate intermediates in formation and export ofmRNA.Mol Cell Biol,2001,21(21):73072-7319.
[22]Mili S,Shu HJ,Zhao Y,et al.Distinct RNP complexes of shuttling hnRNP proteins with pre2mRNA and mRNA:candidate intermediates in formation and export of mRNA.Mol Cell Bio1,2001,21(21):73072-7319.
[23]CHEN J,RASENICK M M.Chronic antidepressant treatment facilitates G protein activation of adenylyl cyclase without altering G protein content[J].J Pharmacol Exp Ther,1995,275(1):509-517.
[24]NIBUYA M,NESTLER E J.DUMAN R S.Chronic antidepressant administration increases the expression of cAMP response element binding protein(CREB)in rat hippocampus[J].J Neurosci,1996,16(7):2365-2372.
[25]LOPEZ J F,CHALMERS D T,LITYLE K Y.et al.Regulation ofserotoninl A,glucocorticoid and mineralocorticoid receptor in rat and human hippoeampus:implications for the neurobiology of depression[J].Biol Psychiatry,1998,43(8):547-73.
[26]王任烨,徐英,蒋文高等.姜黄素对慢性应激大鼠不同脑区cAMP水平及腺苷酸环化酶活性的影响.中国药学杂志,2007,42(2):121-124.
[27]Shibuya M,Hirai S,Seto M,et al.Effects of fasudil in acute ischemic stroke:results of a prospective placebo-controlled double-blind trial[J].J Neurol Sci,2005,238(1):31-39.
[28]Rege TA,Pallero MA,Gomez C,et al.Thy-1,via its GPI anchor,modulates Src family kinase and focal adhesion kinase phosphorylation and subcellular localization,and fibroblast migration,in response to thrombospondin-1/hep I.Exp Cell Res 2006;312(19):3752-3767.
[29]Gomes N,Legrand C,Fauvel-Lafeve F.Shear stress induced release of yon Willebrand factor and thrombospondin-1 in HUVEC extracellular matrix enhances breast tumour cell adhesion.Clin Exp Metastasis 2005;22(3):215-223.
[30]Esemuede N,Lee T,Pierre-Paul D,et al.The role of thrombospondin-1 in human disease.J Surg Res 2004;122(1):135-142.
[31]Forslow A,Liu Z,Sundqvist KG.Receptor communication within the lymphocyte plasma membrane:a role for the thrombospondin family of matricellular proteins.Cell Mol Life Sci 2007;64(1):66-76.
[32]Grant MA,Kalluri R.Structural basis for the functions of endogenous angiogenesis inhibitors.Cold Spring Harb Symp Quant Biol 2005;70:399-410.
[33]Browne PV,Mosher DF,Steinberg MH,et al.Disturbance of plasma and platelet thrombospondin levels in sickle cell disease.Am J Hematol 1996;51(4):296-301.
[34]RayChaudhury A,Frazier WA,D'Amore PA.Comparison of normal and tumorigenic endothelial cells:differences in thrombospondin production and responses to transforming growth factor-beta.JCell Sci 1994;107(Pt 1):39-46.
[35]Czlonkowska A,Cyrta B,Korlak J Immunological observations on patients with acute cerebral vascular disease[J].JNeurol SCI,1979,43(3):455-464.
[36]N ljtmans LG;DE jong L,ARTAL2SANZM,et al.Prohibitins act as amembrane2bound chaperone for the stabilization of mitochondrial proteins[J].EMBO J,2000,19(11):2444-2451.
[37]RAJAL INGAM K,WUNDER C,BR INKMANN V,et al.Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration[J].N at Cell Biol,2005,7(8):837-843.
[38]Hershel R,Barbara MJ,Eric DB,et al.The effect ofhypoxia from birth on the regulation of aldosterone in the 7-day-old rat:plasma hormones,steroidogenesis in vitro,and steroidogenic enzyme messenger ribonucleic acid[J].Endocrinology,1999,140:3147-3153.
[1]Wright AF.Neurogenetics Ⅱ:complex disorders.J Neurol Neurosurg Psychiatry.2005 May;76(5):623-31.
[2]Pandey A,Mann M.Proteomics to study genes and genomes.Nature,2000,405:837-846.
[3]Blackstock WP,Weir MP.Proteomics:quantitative and physical mapping of cellular proteins.Biotechnol,1999,17(3):121-127.
[4]Prabhakaran S,Rundek T,Luo X,et al.Carotid plaque surface ir-regularity predicts ischemic stroke:the Northern Manhattan Study.Stroke,2006,37:643.
[5]Okamoto K,Yamori Y,Nagaoka A.Establishment of the stroke-prone spontaneously hypertensive rats(SHR).Circ Res.1974;33/34:I-143-I-153.
[6]Yamori Y,Horie R,Tanase H,etal.Possible role of nutritional factors in the incidence lesions in stroke-prone spontaneously hypertensive rats.Hypertension.1984;6:49-53.
[7]Volpe M,Russo R,Vecchione C,etal.Endothelial dysfunction and genetic predisposition to stroke in spontaneously hypertensive rats.J Hypertens.1998;16(suppl 8):S31-S35.
[8]Sironi L,Tremoli E,Miller I.Acute-phase proteins before cerebral ischemia in stroke-prone rats:identification by proteomics.Stroke.2001 Mar;32(3):753-60.
[9]Sironi L,GuerriniU,Tremoli E.Analysis of pathological events at the onset of brain damage in stroke-prone rats:a protenomics and magnetic resonance imaging approach.J Neurosci Res.2004 Octl;78(1):115-22.
[10]Fornage M,Swank MW,Boerwinkle E.Gene expression profiling and functional proteomic analysis reveal perturbed kinase-mediated signaling in genetic stroke susceptibility.Physiol Genomics,2003,Sep 29;15(1):75-83.
[11]RaneMJ,GozalD,ButtW.Gamma-amino butyric during ischemia-reperfusion.J Immunol.2005,Junl;174(11):7492-9.
[12]Schrattenholz A.Proteomics:how to control highly dynamic patterns of millions of molecules and interpret changes correctly?Drug Discov Today Technol 2004;1(1):1-8.
[13]Sommer S,Hunzinger S,Hunzinger C,Schillo S,etal.Molecular analysis of homocysteic acid-induced neuronal stress.J Proteome Res 2004;3(3):572-81.
[14]Klemm M,Schrattenholz A.Neurotoxicity of active compounds establishment of hESC-lines and proteomics technologies for human embryo- and neurotoxicity-screening and biomarker identification.ALTEX 2004;21(1):12-19.
[15]Schrattenholz A,Wozny W,Klemm M.Differential and quantitative molecular analysis of ischemia complexity reduction by isotopic labeling of proteins using a neural embryonic stem cell model,J.Neurol Sci.2005 Mar 15:229-230.
[16]Magavi,S.S,Leavitt,B.R.,and Macklis,J.D.Introduction of neurogenesis in the neocortex of adult mice.Nature(London)405,951-955.
[17]Cameron,H.A.,Hazel,T.G.,and Mckay,R.D.Regulation of neurogenesis by growth factors and neurotransmitters.J.Neurobiol.1998,36,287-306.
[18]Sobel,A,Boutterin,M.C.,Beretta,L.,et al.Intracellular substrates for extracellar signaling.Characterization of a ubiquitous,neuron-enriched phosphoprotein(stathmin).J.Biol.Chem.1989,263,12813-12815.
[19]Curmi,P.A.,Andersen,S.S,Lachkar,S.,et al.The stathmin/tubulin interaction in vitro.J.Biol.Chem.1997,272,25029-25036.
[20]Jin K,Mao XO,Cottrell B,et al.Proteomie and immunochemical characterization of a role for stathmin in adult neurogenesis.FASEB J.2004 Feb;18(2):287-99.
[21]赵晓峰,温景荣,石学敏,等.正常与脑缺血大鼠的脑皮质蛋白质差异分析鉴定.生物工程学报,2005,21(6):934-941.
[22]李镕源.醒脑开窍针法对局灶性脑缺血模型大鼠基底节蛋白质组学影响的研究.2005,中国优秀博硕士学位论文全文数据库.
[23]陈亮.前脑缺血后大鼠海马CA1区亚蛋白质组表达谱的变化,2005,中国优秀博硕士学位论文全文数据库.
[24]Ballabh P,Braun A,Nedergaard M.The blood-brain barrier:an overview:structure,regulation,and clinical implieations[J].Neurobiol Dis,2004,16(1):1-13.
[25]ShustaEV,Blood-brain barrier genomies,proteomics,and new transporter discovery[J].NeuroRx,2005,2(1):151-161.
[26]ShustaEV,Boado R.J,Pardridge W M.Vascular proteomics and subtractive antibody expression cloning[J].Mol Cell Proteom,2002,1:75-82.
[27]Kirsch T,Wellner M,Luft F C,et al.Altered gene expression in cerebral capillaries of stroke-prone spontaneously hypertensive rats[J].Brain Res,2001,910:106-115.
[28]Haqqani,A.S.etal.Characterization of vascular protein expression patterns in cerebral ischemia/reperfusion using laser capture microdissection and ICAT-nanoLC-MS/MS.FASEB J,2005,19,1809-1821.
[29]Calabria AR,Shusta EV.Blood-brain barrier genomics and proteomics:elucidating phenotype,identifying disease targets and enabling brain drug delivery.Drug Discov Today.2006,Sep;11(17-18):792-9.
[30]Davies,P.F,Jenny Z,Brian P.Spatial Microstimuli in Endothelial Mechanosignaling.Circulation Research.2003;92:359.
[31]Glagov,S.,Zarins,C.,Giddens,D＞P.,and Ku,D.N.(1998)Arch.Pathol.Lab.Med.1998,112:1018-1031.
[32]Davies,P.E,Shi,C.,Depaola,N.,Helmke,B.P.,and Polacek,D.C.(2001)Ann.N.Y.Acad.Sci.2001,947:7-17.
[33]Pelliux C,Desgeorges A,Pigeon CH,Chambaz C,Yin H,Hayoz D,etal.Cap G,a gelsolin family protein modulating protective effects of unidirectional shear stress.J Biol Chem 2003;278:29136-44.
[34]Nwasokwa,O.N.(1995)Coronary artery bypass graft disease.Ann.Intern.Meal.1995,123:528-545.
[35]McGregor E,Kempster L,Wait R,Gosling M,Dunn MJ,Powel JT.F-actin capping(CapZ)and other contractile saphenous vein smooth muscle proteins are altered by hemodynamic stress.Mol Cell Proteomics 2004;3:115-24.
[36]Bosman FT,Stamenkovic I.Functional structure and composition of the extracellular matrix.J Pathol,2003,200:423-428.
[37]Rosenfeldt,F.L.,Long J,Wang G,Repression of Smad4 transcriptional activity by SUMO modification.Biochem J,2004,379(Pt 1):23-29.
[38]Dupont A,Corseaux D,Dekeyzer O,Drobecq H,Guinot AL,Susen S,etal.The proteome and secretome of human arterial smooth muscle cells.Proteomics 2005;585-96.
[39]Lupu F,Bergonzelli GE,Heim DA,Cousin E,Genton CY,Bachmann F,etal.Localization and production of plasminogen activator inhibitor-1 in human and atherosclerotic arteries.Artefioscler Thromb 1993;13:1090-100.
[40]Liao DF,Jin ZG,Bass AS,Daum G,Gygi SP,Aebersold R,etal.Purification and identification of secreted oxidative stress-induced factors from vascular smooth muscle cells.J Biol Chem 2000;275:189-96.
[41]Ross.R.The pathogenesis of atherosclerosis:a perspective for the 1990s.Nature,1993,29(362):801-809.
[42]Owens.G,Am.J.Control of hypertrophic versus hyperplastic growth of vascular smooth muscle cells Physiol.1998,257:H1755-H1765.
[43]Patton WF,Erdjument-Bromage H,Marks AR,Tempst P,Taubman MB.Components of the protein synthesis and folding machinery and hyperplastic agents.Identification by comparative protein phenotyping and microsequencing.J Biol Chem 1995;270:21404-10.
[44]Jang WG,Kim HS,Park KG;Park YB,Yoon KH,Han SW,etal.Analysis of proteome and transcriptome of tumor necrosis factor alpha stimulated vascular smooth muscle cells with or without alpha lipoic acid.Proteomics 2004;4:3383-93.
[45]吕俊萍,王树人,马增春,等.运用蛋白质组学技术研究TNF-α对血管内皮细胞 的作用机制[J].中国病理生理杂志,2004,20(7):1121-1125.
[46]Verhoeckx KC,Bijlsma S,de Groene EM,wilkamp PF,van der Greer J,Rodenburg RJ.A combination of proteomics,principal component analesis and transcriptomics is a powerful tool for the identification of biomarkers for macrophage maturation in the U937 cell line.Proteomics 2004;4:1014-28.
[47]Gadgil HS,Pabst KM,Giorgianni F,Umstot ES,Desidefio DM,Beranova-Giorgianni S,etal.proteome of monocytes primed with lipopolysaccharide:analysis of the abundant proteins.Proteomics2003;3:1767-80.
[48]崔丽艳,张捷,王天成.同型半胱氨酸刺激大鼠动脉平滑肌细胞增生功能蛋白质组的初步研究[J].医学研究生学报,2004;17(4):315-318.
[49]You SA,Archacki SR,Angheloiu G,Moravee CS,Rao SR,Kinter M,et al.Proteomie approach to coronary atherosclerosis shows ferritin light chain as a significant marker:evidence consistent with iron hypothesis in atherosclerosis.Physiol Crenomics 2003;13:25-30.
[50]Donners MMPC,Verluyten MJ,Bouwman FG,Mariamn ECM,Devreese B,Vanrobaeys F,etal.Proteomie analysis of differential protein expression in human atherosclerotie plaque progression.J Pathol 2005;206:39-45.
[51]Martinet W,Schrijvers DM,De Meyer GR,Herman AG,Kockx MM.Western array analysis of human atherosclerotic plaques:down-regulation of apoptosis-linked gene 2.Cardiovase Res 2003;60:259-67.
[52]Duran MC,Mas S,Martin-Venture JL,Meilhae O,Gallego-Delgado J,et al.Proteomie analysis of human vessel:application to the atherosclerotie plaques.Proteomics.2003;3:973-8.
[53]Fach EM,Garulacan LA,Gao J,Xiao Q,Storm SM,Dubaquie YP,et al.In vitro biomarker discovery for atheroselerosis by proteomics.Molecular & Cellular Proteomics,2004,10(3)1200-1210.
[54]Fuchs D,Erhard P,Turner R,etal.Genistein reverses changes of the proteome induced by oxidiaed-LDL in EA,hy 926 human endothelial cell.[J]Proteome Res,2005;4(2):369-376.
[55]王东生,陈方平,袁肇凯,等.茵陈五苓散对动脉粥样硬化大鼠蛋白质组学的影响[J].浙江中医学院学报,205,29(1):41-44.
[56]马增春,高月,谭洪玲,等.复方丹参方对TNF-α刺激血管平滑肌细胞影响的蛋白质组学研究[J].中国药学通报,2006,22(1):49-54.
[57]Murry CE,Jennings RB,Reimer KA,etal.Preconditioning with ischemia:a delay of lethal cell injury in ischemie myoeardium[J],Circulation,1986,74(5):1124.
[58]Kitagawa K,Matsumoto M,Tagaya M,etal.Jschemic tolerance phenomenon found in the brain[J].Brain Res,1990,528(1):21.
[59]Glazier SS,Rourke DM,Graham DI,etal.Induction of ischemic tolerance following brief focal ischemia in rat brain[J].J Cereb Blood Flow Metab,1994Jul;14(4):545-53.
[60]Dhodda VK,Sailor KA,Bowen KK.Putative endogenous mediators of preconditioning-induced ischemic tolerance in rat brain identified by genomic and proteomic analysis.J Neurochem.2004Apr;89(1):73-89.
[61]高光洁,赵宏,王风学。缺血缺氧性脑损伤中热休克蛋白70表达及其意义[J].国外医学麻醉学与复苏分册,2002,23(5):267
[62]Bernaudin M,Marti HH,Roussel S,etal.A potential role for erythropoietin in focal permanent cerebral ischemia in mice.J Cereb Blood Flow Metab,1999,19:643-651.
[63]Siren AL,Knerlich F,Poser W,etal.Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain.Acta Neuropathol(Berl),2001,101:271-276.
[64]Siren AL,Fratelli M,Brines M,etal.Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress.Proc Natl Acad Sci USA.2001,27,98:4044-4049.
[65]Agnello D,Bigini P,Villa P,etal.Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis.Brain Res,2002,9(52):128-134
[66]Wang CH,Liang CL,Huang LT,etal.Singel intravenous injection of naked plasmid DNA encoding erythropoietin provides neuroprotection in hypoxia-ischemia rats.Biochem Binphys Res Commun,2004,3(14):1064-1071
[67]Wang X,Zhu C,Wang X.the nonerythropoietic asialoerythropoietin protects against hypoxia-ischemia as potenely as erythropoietin.J Neurochem,2004Nov;91(4):900-10.
[68]Bark I.C.,Hahn K.M.,Ryabinin A.E.etal.Differential expression of SNAP-25protein isforms during divergent vesicle fusion events of neural development.Proc.Natl Acad.Sci.USA 92,1995:1510-1514
[69]Morikawa Y.,Nishida H.,Misawa K.etal.Induction of synaptosomal-associated protein-23kD(SNAP-23)by various cytokines.Blood92,1998:129-135
[70]Nagy G.,Reim K.,Matti U.etal.Regulation of releasable vesicle pool sizes by protein kinase A-dependent phosphorylation of SNAP-25.Neuron 41,2004:417-429
[71]Sickmann A,Dormeyer W,Wortelkamp S,etal.Identification of proteins from human cerebrospinal fluid,separated by two-dimensional polyacrylamide gel electrophoresis[J].Electrophoresis,2000,21(13):2721-2728
[72]Davidsson P,Folksson S,Christiansson M,etal.Identification of proteins in human cerebrospinal fluid using liquid-phase isoelectric focusing as a prefractionation step followed by two-dimensionel gel electrophoresis and matris-assisted laser desorption/ionistation mass spectrometry[J].Rapid Commu Mass Sp,2002,16(22):2083-2088
[73]Aurell A,rosengren LE,Karlsson B,Olsson JE,Zbornikova V,Haglid KG.Determination of S100and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction Stroke,1991,22(10):1254-1258
[74]Lescuyer P,Allard L,Zimmerman-Ivol CG etal.Identification of post-mortem cerebrospinal fluid proteins as potential biomarkers of ischemia and neurodegeneration.Proteomics,2004,4(8):2234-2241
[75]Zimmermann-Ivol CG,Burkhard PR,Le Floch-Rohr J,Allard L,Hochstrasser DF,Sanchez JC,Fatty acid binding protein as a serum marker for the early diagnosis of stroke:a pilor study.Mol Cell Proteomics,2004,3(1):66-72
[76]Hesse C,Rosengren L,Andreasen N etal.Transient increase in total tau but not phosphor-tau in human cerebrospinal fluid after acute stroke.Neurosci Lett,2001,297(3):187-190
[77]Karkela J,Bock E,Kaukinen S.CSFand serum brain-specific creatine kinase isoenzyme(CK-BB),neuron-specific enolase(NSE)and neural cell adhesion molecule(NCAM)as prognostic markers for hypoxic brain injury after cardiac arrest in man.J.Neurol.Sci.1993,116(1),100-109
[78]Romeo MJ,ESpina V,Lowenthal M.CSF proteome:a protein repository for potential biomarker identification.Expert Rev Proteomics.2005 Jan;2(1):57-70.
[79]何华,杨燕,王雪楠等.急性脑梗死患者脑脊液蛋白质组学分析.济宁医学院学报,2006,29(1):12-13.
[80]Reynolds MA,Kirchick HJ,Dahlen JR etal.Early biomarkers of stroke.Clin Chem,2003,49(10):1733-1739
[81]Reynolds MA,Kirchick HJ,Dahlen JR etal.Early biomarkers of stroke.Clin Chem,2003,49(10):1733-1739
[82]Missler U,Wiesmann M.Measurement of S-100 protein in human blood and cerebrospinal fluid:analytical method and preliminary clinical result.Eur.J.Clin.Chem.Clin.Biochem.1995,33(10),743-748
[83]Missler U,Wiesmann M,Friedrich C,Kaps M,S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke.Stroke,1997,28(10):1956-1960
[84]Martens P,Raabe A,Johnsson P.SerumS-100 and neuron-specific enolase for prediction of regaining consciousness aider global ischemia.Stroke,1998,29(11)2363-2366
[85]Lynch JR,Blessing R,White WD,Grocott HP,Newman MF,Laskowitz DT.Novel diagnostic test for acute stroke.Stroke,2004,35(1):57-63
[2]金益强,黎杏群,胡随瑜,等。.肝风内动证三亚型的病理生理学基础研究.中国中西结合杂志,1993,13(7):391-397.
[3]王顺道,杜梦华,解庆凡,等.中风病急性期证候演变规律的研究[J].中国中医急症,1996,5(3):121-124.
[4]金益强冲医肝脏象现代研究与临床.人民卫生出版社,北京.2000,2(1):226-227,238,240-241.
[5]潘其民,陈国林,赵玉秋,等.中医肝病流行病学调查.中西医结合杂志 1991;11(3):153-155.
[6]申维玺.论中医证本质的科学内涵.中国中医基础医学杂志 2001;7(6):410-414.
[7]Wright AF.Neurogenetics Ⅱ:complex disorders.J Neurol Neurosurg Psychiatry.2005 May;76(5):623-31.
[8]中华神经科学会.各类脑血管疾病诊断要点[J].中华内科杂志,1996;29(6):379.
[9]郑莜萸主编.中药新药治疗中风的临床指导原则.北京:中国医药科技出版社,2002.
[10]陈肃标,谢素和,曾庆馀.提高外周血淋巴细胞梯度离心分离率,汕头大学医学院学报;2001,14(2):135-137.
[11]Bradford MM.A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Anal Biochem 1976;72:248-54.
[12]Kurt K,Michael F,Gert L.A rat brain protein expression map including cytosolic and enriched mitochondfial and microsomal fractions.Electrophoresis,2003,24,1847-1870.
[13]李家邦,李瑛,熊国良,等.肝阳化风证病理生理学基础的进一步研究湖南医科大学学报 2000,25(4):343-346.
[14]Gendron A,Teitelbaum J,Cossene C,et al Tempo ral effects of left versus right middle cerebral artery occlusion on spleen lymphoc yte subsets and mitogeic response inWistar rats[J]Brain Res,2002,955(1-2)85-97.
[15]Campsnells M,Sciorati C,Tarozzo G,et al.Flow cytometric analysis of inflammatory cells in ischemic rat brain[J]Stroke,2002,33(2):586-592.
[16]Gulesserian T,Kim S H,Fountoulakis M,et al.Aberrant expression of centractin and capping proteins,integral constituents of the dynactin complex,in fetal down syndrome brain[J].Biochem Biophys Res Commun,2002,291(1):62-67.
[17]Burridge K,Chrzanowska-Wodnicka M.Focal adhesions,contractility,and signaling[J].Annu Rev Cell Dev Biol,1996,12:463-518.
[18]Borowsky ML,Hynes RO.Layilin,a novel talin- binding transmembrane protein homologous with C-type lectins,is localized in membrane ruffles[J].J Cell Biol,1998,143(2):429-442.
[19]Izard T,Evans G,Borgon RA,et al.Vinculin activation by talin through helical bundle conversion[J].Nature,2004,427(6970):171-175.
[20]Bois PR,O′Hara BP,Nietlispach D,et al.The vinculin binding sites of talin and alpha- actinin are sufficient to activate vinculin[J].J Biol Chem,2006,281(11):7228-7236.
[21]Mili S,Shu HJ,Zhao Y,et al.Distinct RNP complexes of shuttling hnRNP proteins with pre2mRNA and mRNA:candidate intermediates in formation and export ofmRNA.Mol Cell Biol,2001,21(21):73072-7319.
[22]Mili S,Shu HJ,Zhao Y,et al.Distinct RNP complexes of shuttling hnRNP proteins with pre2mRNA and mRNA:candidate intermediates in formation and export of mRNA.Mol Cell Bio1,2001,21(21):73072-7319.
[23]CHEN J,RASENICK M M.Chronic antidepressant treatment facilitates G protein activation of adenylyl cyclase without altering G protein content[J].J Pharmacol Exp Ther,1995,275(1):509-517.
[24]NIBUYA M,NESTLER E J.DUMAN R S.Chronic antidepressant administration increases the expression of cAMP response element binding protein(CREB)in rat hippocampus[J].J Neurosci,1996,16(7):2365-2372.
[25]LOPEZ J F,CHALMERS D T,LITYLE K Y.et al.Regulation ofserotoninl A,glucocorticoid and mineralocorticoid receptor in rat and human hippoeampus:implications for the neurobiology of depression[J].Biol Psychiatry,1998,43(8):547-73.
[26]王任烨,徐英,蒋文高等.姜黄素对慢性应激大鼠不同脑区cAMP水平及腺苷酸环化酶活性的影响.中国药学杂志,2007,42(2):121-124.
[27]Shibuya M,Hirai S,Seto M,et al.Effects of fasudil in acute ischemic stroke:results of a prospective placebo-controlled double-blind trial[J].J Neurol Sci,2005,238(1):31-39.
[28]Rege TA,Pallero MA,Gomez C,et al.Thy-1,via its GPI anchor,modulates Src family kinase and focal adhesion kinase phosphorylation and subcellular localization,and fibroblast migration,in response to thrombospondin-1/hep I.Exp Cell Res 2006;312(19):3752-3767.
[29]Gomes N,Legrand C,Fauvel-Lafeve F.Shear stress induced release of yon Willebrand factor and thrombospondin-1 in HUVEC extracellular matrix enhances breast tumour cell adhesion.Clin Exp Metastasis 2005;22(3):215-223.
[30]Esemuede N,Lee T,Pierre-Paul D,et al.The role of thrombospondin-1 in human disease.J Surg Res 2004;122(1):135-142.
[31]Forslow A,Liu Z,Sundqvist KG.Receptor communication within the lymphocyte plasma membrane:a role for the thrombospondin family of matricellular proteins.Cell Mol Life Sci 2007;64(1):66-76.
[32]Grant MA,Kalluri R.Structural basis for the functions of endogenous angiogenesis inhibitors.Cold Spring Harb Symp Quant Biol 2005;70:399-410.
[33]Browne PV,Mosher DF,Steinberg MH,et al.Disturbance of plasma and platelet thrombospondin levels in sickle cell disease.Am J Hematol 1996;51(4):296-301.
[34]RayChaudhury A,Frazier WA,D'Amore PA.Comparison of normal and tumorigenic endothelial cells:differences in thrombospondin production and responses to transforming growth factor-beta.JCell Sci 1994;107(Pt 1):39-46.
[35]Czlonkowska A,Cyrta B,Korlak J Immunological observations on patients with acute cerebral vascular disease[J].JNeurol SCI,1979,43(3):455-464.
[36]N ljtmans LG;DE jong L,ARTAL2SANZM,et al.Prohibitins act as amembrane2bound chaperone for the stabilization of mitochondrial proteins[J].EMBO J,2000,19(11):2444-2451.
[37]RAJAL INGAM K,WUNDER C,BR INKMANN V,et al.Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration[J].N at Cell Biol,2005,7(8):837-843.
[38]Hershel R,Barbara MJ,Eric DB,et al.The effect ofhypoxia from birth on the regulation of aldosterone in the 7-day-old rat:plasma hormones,steroidogenesis in vitro,and steroidogenic enzyme messenger ribonucleic acid[J].Endocrinology,1999,140:3147-3153.
[1]Wright AF.Neurogenetics Ⅱ:complex disorders.J Neurol Neurosurg Psychiatry.2005 May;76(5):623-31.
[2]Pandey A,Mann M.Proteomics to study genes and genomes.Nature,2000,405:837-846.
[3]Blackstock WP,Weir MP.Proteomics:quantitative and physical mapping of cellular proteins.Biotechnol,1999,17(3):121-127.
[4]Prabhakaran S,Rundek T,Luo X,et al.Carotid plaque surface ir-regularity predicts ischemic stroke:the Northern Manhattan Study.Stroke,2006,37:643.
[5]Okamoto K,Yamori Y,Nagaoka A.Establishment of the stroke-prone spontaneously hypertensive rats(SHR).Circ Res.1974;33/34:I-143-I-153.
[6]Yamori Y,Horie R,Tanase H,etal.Possible role of nutritional factors in the incidence lesions in stroke-prone spontaneously hypertensive rats.Hypertension.1984;6:49-53.
[7]Volpe M,Russo R,Vecchione C,etal.Endothelial dysfunction and genetic predisposition to stroke in spontaneously hypertensive rats.J Hypertens.1998;16(suppl 8):S31-S35.
[8]Sironi L,Tremoli E,Miller I.Acute-phase proteins before cerebral ischemia in stroke-prone rats:identification by proteomics.Stroke.2001 Mar;32(3):753-60.
[9]Sironi L,GuerriniU,Tremoli E.Analysis of pathological events at the onset of brain damage in stroke-prone rats:a protenomics and magnetic resonance imaging approach.J Neurosci Res.2004 Octl;78(1):115-22.
[10]Fornage M,Swank MW,Boerwinkle E.Gene expression profiling and functional proteomic analysis reveal perturbed kinase-mediated signaling in genetic stroke susceptibility.Physiol Genomics,2003,Sep 29;15(1):75-83.
[11]RaneMJ,GozalD,ButtW.Gamma-amino butyric during ischemia-reperfusion.J Immunol.2005,Junl;174(11):7492-9.
[12]Schrattenholz A.Proteomics:how to control highly dynamic patterns of millions of molecules and interpret changes correctly?Drug Discov Today Technol 2004;1(1):1-8.
[13]Sommer S,Hunzinger S,Hunzinger C,Schillo S,etal.Molecular analysis of homocysteic acid-induced neuronal stress.J Proteome Res 2004;3(3):572-81.
[14]Klemm M,Schrattenholz A.Neurotoxicity of active compounds establishment of hESC-lines and proteomics technologies for human embryo- and neurotoxicity-screening and biomarker identification.ALTEX 2004;21(1):12-19.
[15]Schrattenholz A,Wozny W,Klemm M.Differential and quantitative molecular analysis of ischemia complexity reduction by isotopic labeling of proteins using a neural embryonic stem cell model,J.Neurol Sci.2005 Mar 15:229-230.
[16]Magavi,S.S,Leavitt,B.R.,and Macklis,J.D.Introduction of neurogenesis in the neocortex of adult mice.Nature(London)405,951-955.
[17]Cameron,H.A.,Hazel,T.G.,and Mckay,R.D.Regulation of neurogenesis by growth factors and neurotransmitters.J.Neurobiol.1998,36,287-306.
[18]Sobel,A,Boutterin,M.C.,Beretta,L.,et al.Intracellular substrates for extracellar signaling.Characterization of a ubiquitous,neuron-enriched phosphoprotein(stathmin).J.Biol.Chem.1989,263,12813-12815.
[19]Curmi,P.A.,Andersen,S.S,Lachkar,S.,et al.The stathmin/tubulin interaction in vitro.J.Biol.Chem.1997,272,25029-25036.
[20]Jin K,Mao XO,Cottrell B,et al.Proteomie and immunochemical characterization of a role for stathmin in adult neurogenesis.FASEB J.2004 Feb;18(2):287-99.
[21]赵晓峰,温景荣,石学敏,等.正常与脑缺血大鼠的脑皮质蛋白质差异分析鉴定.生物工程学报,2005,21(6):934-941.
[22]李镕源.醒脑开窍针法对局灶性脑缺血模型大鼠基底节蛋白质组学影响的研究.2005,中国优秀博硕士学位论文全文数据库.
[23]陈亮.前脑缺血后大鼠海马CA1区亚蛋白质组表达谱的变化,2005,中国优秀博硕士学位论文全文数据库.
[24]Ballabh P,Braun A,Nedergaard M.The blood-brain barrier:an overview:structure,regulation,and clinical implieations[J].Neurobiol Dis,2004,16(1):1-13.
[25]ShustaEV,Blood-brain barrier genomies,proteomics,and new transporter discovery[J].NeuroRx,2005,2(1):151-161.
[26]ShustaEV,Boado R.J,Pardridge W M.Vascular proteomics and subtractive antibody expression cloning[J].Mol Cell Proteom,2002,1:75-82.
[27]Kirsch T,Wellner M,Luft F C,et al.Altered gene expression in cerebral capillaries of stroke-prone spontaneously hypertensive rats[J].Brain Res,2001,910:106-115.
[28]Haqqani,A.S.etal.Characterization of vascular protein expression patterns in cerebral ischemia/reperfusion using laser capture microdissection and ICAT-nanoLC-MS/MS.FASEB J,2005,19,1809-1821.
[29]Calabria AR,Shusta EV.Blood-brain barrier genomics and proteomics:elucidating phenotype,identifying disease targets and enabling brain drug delivery.Drug Discov Today.2006,Sep;11(17-18):792-9.
[30]Davies,P.F,Jenny Z,Brian P.Spatial Microstimuli in Endothelial Mechanosignaling.Circulation Research.2003;92:359.
[31]Glagov,S.,Zarins,C.,Giddens,D＞P.,and Ku,D.N.(1998)Arch.Pathol.Lab.Med.1998,112:1018-1031.
[32]Davies,P.E,Shi,C.,Depaola,N.,Helmke,B.P.,and Polacek,D.C.(2001)Ann.N.Y.Acad.Sci.2001,947:7-17.
[33]Pelliux C,Desgeorges A,Pigeon CH,Chambaz C,Yin H,Hayoz D,etal.Cap G,a gelsolin family protein modulating protective effects of unidirectional shear stress.J Biol Chem 2003;278:29136-44.
[34]Nwasokwa,O.N.(1995)Coronary artery bypass graft disease.Ann.Intern.Meal.1995,123:528-545.
[35]McGregor E,Kempster L,Wait R,Gosling M,Dunn MJ,Powel JT.F-actin capping(CapZ)and other contractile saphenous vein smooth muscle proteins are altered by hemodynamic stress.Mol Cell Proteomics 2004;3:115-24.
[36]Bosman FT,Stamenkovic I.Functional structure and composition of the extracellular matrix.J Pathol,2003,200:423-428.
[37]Rosenfeldt,F.L.,Long J,Wang G,Repression of Smad4 transcriptional activity by SUMO modification.Biochem J,2004,379(Pt 1):23-29.
[38]Dupont A,Corseaux D,Dekeyzer O,Drobecq H,Guinot AL,Susen S,etal.The proteome and secretome of human arterial smooth muscle cells.Proteomics 2005;585-96.
[39]Lupu F,Bergonzelli GE,Heim DA,Cousin E,Genton CY,Bachmann F,etal.Localization and production of plasminogen activator inhibitor-1 in human and atherosclerotic arteries.Artefioscler Thromb 1993;13:1090-100.
[40]Liao DF,Jin ZG,Bass AS,Daum G,Gygi SP,Aebersold R,etal.Purification and identification of secreted oxidative stress-induced factors from vascular smooth muscle cells.J Biol Chem 2000;275:189-96.
[41]Ross.R.The pathogenesis of atherosclerosis:a perspective for the 1990s.Nature,1993,29(362):801-809.
[42]Owens.G,Am.J.Control of hypertrophic versus hyperplastic growth of vascular smooth muscle cells Physiol.1998,257:H1755-H1765.
[43]Patton WF,Erdjument-Bromage H,Marks AR,Tempst P,Taubman MB.Components of the protein synthesis and folding machinery and hyperplastic agents.Identification by comparative protein phenotyping and microsequencing.J Biol Chem 1995;270:21404-10.
[44]Jang WG,Kim HS,Park KG;Park YB,Yoon KH,Han SW,etal.Analysis of proteome and transcriptome of tumor necrosis factor alpha stimulated vascular smooth muscle cells with or without alpha lipoic acid.Proteomics 2004;4:3383-93.
[45]吕俊萍,王树人,马增春,等.运用蛋白质组学技术研究TNF-α对血管内皮细胞 的作用机制[J].中国病理生理杂志,2004,20(7):1121-1125.
[46]Verhoeckx KC,Bijlsma S,de Groene EM,wilkamp PF,van der Greer J,Rodenburg RJ.A combination of proteomics,principal component analesis and transcriptomics is a powerful tool for the identification of biomarkers for macrophage maturation in the U937 cell line.Proteomics 2004;4:1014-28.
[47]Gadgil HS,Pabst KM,Giorgianni F,Umstot ES,Desidefio DM,Beranova-Giorgianni S,etal.proteome of monocytes primed with lipopolysaccharide:analysis of the abundant proteins.Proteomics2003;3:1767-80.
[48]崔丽艳,张捷,王天成.同型半胱氨酸刺激大鼠动脉平滑肌细胞增生功能蛋白质组的初步研究[J].医学研究生学报,2004;17(4):315-318.
[49]You SA,Archacki SR,Angheloiu G,Moravee CS,Rao SR,Kinter M,et al.Proteomie approach to coronary atherosclerosis shows ferritin light chain as a significant marker:evidence consistent with iron hypothesis in atherosclerosis.Physiol Crenomics 2003;13:25-30.
[50]Donners MMPC,Verluyten MJ,Bouwman FG,Mariamn ECM,Devreese B,Vanrobaeys F,etal.Proteomie analysis of differential protein expression in human atherosclerotie plaque progression.J Pathol 2005;206:39-45.
[51]Martinet W,Schrijvers DM,De Meyer GR,Herman AG,Kockx MM.Western array analysis of human atherosclerotic plaques:down-regulation of apoptosis-linked gene 2.Cardiovase Res 2003;60:259-67.
[52]Duran MC,Mas S,Martin-Venture JL,Meilhae O,Gallego-Delgado J,et al.Proteomie analysis of human vessel:application to the atherosclerotie plaques.Proteomics.2003;3:973-8.
[53]Fach EM,Garulacan LA,Gao J,Xiao Q,Storm SM,Dubaquie YP,et al.In vitro biomarker discovery for atheroselerosis by proteomics.Molecular & Cellular Proteomics,2004,10(3)1200-1210.
[54]Fuchs D,Erhard P,Turner R,etal.Genistein reverses changes of the proteome induced by oxidiaed-LDL in EA,hy 926 human endothelial cell.[J]Proteome Res,2005;4(2):369-376.
[55]王东生,陈方平,袁肇凯,等.茵陈五苓散对动脉粥样硬化大鼠蛋白质组学的影响[J].浙江中医学院学报,205,29(1):41-44.
[56]马增春,高月,谭洪玲,等.复方丹参方对TNF-α刺激血管平滑肌细胞影响的蛋白质组学研究[J].中国药学通报,2006,22(1):49-54.
[57]Murry CE,Jennings RB,Reimer KA,etal.Preconditioning with ischemia:a delay of lethal cell injury in ischemie myoeardium[J],Circulation,1986,74(5):1124.
[58]Kitagawa K,Matsumoto M,Tagaya M,etal.Jschemic tolerance phenomenon found in the brain[J].Brain Res,1990,528(1):21.
[59]Glazier SS,Rourke DM,Graham DI,etal.Induction of ischemic tolerance following brief focal ischemia in rat brain[J].J Cereb Blood Flow Metab,1994Jul;14(4):545-53.
[60]Dhodda VK,Sailor KA,Bowen KK.Putative endogenous mediators of preconditioning-induced ischemic tolerance in rat brain identified by genomic and proteomic analysis.J Neurochem.2004Apr;89(1):73-89.
[61]高光洁,赵宏,王风学。缺血缺氧性脑损伤中热休克蛋白70表达及其意义[J].国外医学麻醉学与复苏分册,2002,23(5):267
[62]Bernaudin M,Marti HH,Roussel S,etal.A potential role for erythropoietin in focal permanent cerebral ischemia in mice.J Cereb Blood Flow Metab,1999,19:643-651.
[63]Siren AL,Knerlich F,Poser W,etal.Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain.Acta Neuropathol(Berl),2001,101:271-276.
[64]Siren AL,Fratelli M,Brines M,etal.Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress.Proc Natl Acad Sci USA.2001,27,98:4044-4049.
[65]Agnello D,Bigini P,Villa P,etal.Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis.Brain Res,2002,9(52):128-134
[66]Wang CH,Liang CL,Huang LT,etal.Singel intravenous injection of naked plasmid DNA encoding erythropoietin provides neuroprotection in hypoxia-ischemia rats.Biochem Binphys Res Commun,2004,3(14):1064-1071
[67]Wang X,Zhu C,Wang X.the nonerythropoietic asialoerythropoietin protects against hypoxia-ischemia as potenely as erythropoietin.J Neurochem,2004Nov;91(4):900-10.
[68]Bark I.C.,Hahn K.M.,Ryabinin A.E.etal.Differential expression of SNAP-25protein isforms during divergent vesicle fusion events of neural development.Proc.Natl Acad.Sci.USA 92,1995:1510-1514
[69]Morikawa Y.,Nishida H.,Misawa K.etal.Induction of synaptosomal-associated protein-23kD(SNAP-23)by various cytokines.Blood92,1998:129-135
[70]Nagy G.,Reim K.,Matti U.etal.Regulation of releasable vesicle pool sizes by protein kinase A-dependent phosphorylation of SNAP-25.Neuron 41,2004:417-429
[71]Sickmann A,Dormeyer W,Wortelkamp S,etal.Identification of proteins from human cerebrospinal fluid,separated by two-dimensional polyacrylamide gel electrophoresis[J].Electrophoresis,2000,21(13):2721-2728
[72]Davidsson P,Folksson S,Christiansson M,etal.Identification of proteins in human cerebrospinal fluid using liquid-phase isoelectric focusing as a prefractionation step followed by two-dimensionel gel electrophoresis and matris-assisted laser desorption/ionistation mass spectrometry[J].Rapid Commu Mass Sp,2002,16(22):2083-2088
[73]Aurell A,rosengren LE,Karlsson B,Olsson JE,Zbornikova V,Haglid KG.Determination of S100and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction Stroke,1991,22(10):1254-1258
[74]Lescuyer P,Allard L,Zimmerman-Ivol CG etal.Identification of post-mortem cerebrospinal fluid proteins as potential biomarkers of ischemia and neurodegeneration.Proteomics,2004,4(8):2234-2241
[75]Zimmermann-Ivol CG,Burkhard PR,Le Floch-Rohr J,Allard L,Hochstrasser DF,Sanchez JC,Fatty acid binding protein as a serum marker for the early diagnosis of stroke:a pilor study.Mol Cell Proteomics,2004,3(1):66-72
[76]Hesse C,Rosengren L,Andreasen N etal.Transient increase in total tau but not phosphor-tau in human cerebrospinal fluid after acute stroke.Neurosci Lett,2001,297(3):187-190
[77]Karkela J,Bock E,Kaukinen S.CSFand serum brain-specific creatine kinase isoenzyme(CK-BB),neuron-specific enolase(NSE)and neural cell adhesion molecule(NCAM)as prognostic markers for hypoxic brain injury after cardiac arrest in man.J.Neurol.Sci.1993,116(1),100-109
[78]Romeo MJ,ESpina V,Lowenthal M.CSF proteome:a protein repository for potential biomarker identification.Expert Rev Proteomics.2005 Jan;2(1):57-70.
[79]何华,杨燕,王雪楠等.急性脑梗死患者脑脊液蛋白质组学分析.济宁医学院学报,2006,29(1):12-13.
[80]Reynolds MA,Kirchick HJ,Dahlen JR etal.Early biomarkers of stroke.Clin Chem,2003,49(10):1733-1739
[81]Reynolds MA,Kirchick HJ,Dahlen JR etal.Early biomarkers of stroke.Clin Chem,2003,49(10):1733-1739
[82]Missler U,Wiesmann M.Measurement of S-100 protein in human blood and cerebrospinal fluid:analytical method and preliminary clinical result.Eur.J.Clin.Chem.Clin.Biochem.1995,33(10),743-748
[83]Missler U,Wiesmann M,Friedrich C,Kaps M,S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke.Stroke,1997,28(10):1956-1960
[84]Martens P,Raabe A,Johnsson P.SerumS-100 and neuron-specific enolase for prediction of regaining consciousness aider global ischemia.Stroke,1998,29(11)2363-2366
[85]Lynch JR,Blessing R,White WD,Grocott HP,Newman MF,Laskowitz DT.Novel diagnostic test for acute stroke.Stroke,2004,35(1):57-63
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |